232 related articles for article (PubMed ID: 32018142)
1. Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites.
Maassel NL; Fleming MM; Luo J; Zhang Y; Pei KY
J Surg Res; 2020 Jun; 250():45-52. PubMed ID: 32018142
[TBL] [Abstract][Full Text] [Related]
2. Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy.
Fleming MM; Liu F; Zhang Y; Pei KY
World J Surg; 2018 Oct; 42(10):3390-3397. PubMed ID: 29541825
[TBL] [Abstract][Full Text] [Related]
3. Region 11 MELD Na exception prospective study.
Fisher RA; Heuman DM; Harper AM; Behnke MK; Smith AD; Russo MW; Zacks S; McGillicuddy JW; Eason J; Porayko MK; Northup P; Marvin MR; Hundley J; Nair S
Ann Hepatol; 2012; 11(1):62-7. PubMed ID: 22166562
[TBL] [Abstract][Full Text] [Related]
4. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
[TBL] [Abstract][Full Text] [Related]
5. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
6. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
7. Ascites: A marker for increased surgical risk unaccounted for by the model for end-stage liver disease (MELD) score for general surgical procedures.
Fleming MM; DeWane MP; Luo J; Zhang Y; Pei KY
Surgery; 2018 Aug; 164(2):233-237. PubMed ID: 29705097
[TBL] [Abstract][Full Text] [Related]
8. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
9. Predicting Operative Outcomes in Patients with Liver Disease: Albumin-Bilirubin Score vs Model for End-Stage Liver Disease-Sodium Score.
Taylor GA; Fagenson AM; Kuo LE; Pitt HA; Lau KN
J Am Coll Surg; 2021 Apr; 232(4):470-480.e2. PubMed ID: 33346079
[TBL] [Abstract][Full Text] [Related]
10. The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy.
Dolejs SC; Beane JD; Kays JK; Ceppa EP; Zarzaur BL
Surg Endosc; 2017 Dec; 31(12):5192-5200. PubMed ID: 28493164
[TBL] [Abstract][Full Text] [Related]
11. MELD-Na score associated with postoperative complications in hernia repair in non-cirrhotic patients.
Schlosser KA; Kao AM; Zhang Y; Prasad T; Kasten KR; Davis BR; Heniford BT; Colavita PD
Hernia; 2019 Feb; 23(1):51-59. PubMed ID: 30446849
[TBL] [Abstract][Full Text] [Related]
12. The impact of Model for End-Stage Liver Disease-Na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease.
Causey MW; Nelson D; Johnson EK; Maykel J; Davis B; Rivadeneira DE; Champagne B; Steele SR
Am J Surg; 2014 Apr; 207(4):520-6. PubMed ID: 24239525
[TBL] [Abstract][Full Text] [Related]
13. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis.
Bajaj JS; Tandon P; OʼLeary JG; Biggins SW; Wong F; Kamath PS; Garcia-Tsao G; Maliakkal B; Lai JC; Fallon M; Thuluvath P; Vargas HE; Subramanian RM; Thacker LR; Reddy RK
Am J Gastroenterol; 2018 Sep; 113(9):1339. PubMed ID: 29880972
[TBL] [Abstract][Full Text] [Related]
15. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
16. The association between the serum sodium level and the severity of complications in liver cirrhosis.
Kim JH; Lee JS; Lee SH; Bae WK; Kim NH; Kim KA; Moon YS
Korean J Intern Med; 2009 Jun; 24(2):106-12. PubMed ID: 19543488
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices.
Kim DH; Kim SH; Kim KS; Lee WJ; Kim NK; Noh SH; Kim CB
ANZ J Surg; 2014 Nov; 84(11):832-6. PubMed ID: 23647879
[TBL] [Abstract][Full Text] [Related]
18. MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy.
Wang J; Wang AJ; Li BM; Liu ZJ; Chen L; Wang H; Shi F; Zhu X
J Clin Gastroenterol; 2014; 48(10):870-7. PubMed ID: 24296420
[TBL] [Abstract][Full Text] [Related]
19. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
[TBL] [Abstract][Full Text] [Related]
20. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
Mazumder NR; Atiemo K; Daud A; Kho A; Abecassis M; Levitsky J; Ladner DP
Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
